# APPROXIMA

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/approxima

- Industry: Healthcare Specialists
- Headquarters: Italy
- Website: www.approximamedical.com/
- Total disclosed funding: $11M
- Latest round: Series A (Mar 31, 2026)
- Investors on record: 4

## About

Based in Italy, and founded in 2020, APPROXIMA provides a tricuspid valve repair system based on a right ventricular reshaping approach. The company was co-founded by Michal Jaworek (CEO) and Edoardo Maroncelli. In March 2026, APPROXIMA raised EUR 8.8 million in series A funding from Aegis Capital. The round was part of a larger EUR 8.8 million in series A funding.


The company offers medication for patients suffering from tricuspid valve regurgitation on a right ventricular reshaping approach. It provides a minimally invasive tricuspid valve repair system that targets the root cause of the pathology and does the ventricle and annulus reshaping.

The company will use the March 2026 funding to develop a novel solution for cardiac surgery addressing clinical needs in the treatment of valvular heart disease.

## Funding rounds

- Series A, Mar 31, 2026, $1.7M — Aegis Capital
- Series A, Feb 20, 2025, $7.7M — Club Degli Investitori, Panakes Partners, ENEA Tech and Biomedical Foundation
- Seed, Feb 6, 2023, $1.7M — Club Degli Investitori, Panakes Partners

## Investors

- Club Degli Investitori (https://capitalatlas.ai/funds/club-degli-investitori) — Seed, Series A
- Panakes Partners (https://capitalatlas.ai/funds/panakes-partners) — Seed, Series A
- ENEA Tech and Biomedical Foundation — Series A
- Aegis Capital (https://capitalatlas.ai/funds/aegis-capital) — Series A